Imagin Medical IncOTC Pink - Limited Information:IMEXFView on Canadian Exchange
- LAST PRICE0.0150
- TODAY'S CHANGE (%)0.0050 (50.0000%)
- Bid / Lots0.0020/ 100
- Ask / Lots0.0386/ 100
- Open / Previous Close0.0150 / 0.0100
- Day Range
- 52 Week Range
- Volume962
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IMEXF |
|---|---|---|
| 11:52 ET | 962 | 0.015 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Imagin Medical Inc | 162.5K | --- | --- |
Company Information
Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.
Contact Information
- Headquarters
- 890 W. Pender Street, Suite 600VANCOUVER, BC, Canada V6C 1J9
- Phone
- 778-998-5000
- Fax
- 604-687-1327
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $162.5K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.8M |
Imagin Medical Inc does not pay a dividend. | |
Beta | 1.08 |
EPS | $-0.33 |
Book Value | $-1.23 |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
